Sánchez-Guijo, Fermin M <br/><br/>
Evaluation of tolerability and efficacy of imatinib mesylate in elderly patients with chronic phase CML: ELDERGLI study.  [electronic resource] 

 -  Leukemia research  Sep 2011 
 - 1184-7 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1873-5835 
<br/><br/><label>Standard No.: </label>10.1016/j.leukres.2011.01.017  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Agents--adverse effects<br/>Benzamides<br/>Cytogenetic Analysis<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Imatinib Mesylate<br/>Leukemia, Myeloid, Chronic-Phase--drug therapy<br/>Male<br/>Middle Aged<br/>Piperazines--adverse effects<br/>Pyrimidines--adverse effects<br/>Survival Analysis<br/>Treatment Outcome